Skip to main content
. 2012 Oct 29;109(46):E3177–E3185. doi: 10.1073/pnas.1213797109

Fig. 4.

Fig. 4.

C5aR/5-LO coexpression in PMNs is required for arthritis. (A and B) A total of 20 × 106 WT or C5ar−/− PMNs were adoptively transferred into Alox5−/− mice (“WT PMNs Inline graphic Alox5−/−” and “C5ar−/− PMNs Inline graphic Alox5−/−”) together with K/BxN serum i.v. on days 0 and 2. Alox5−/− mice receiving only K/BxN serum served as controls. Mice were clinically scored daily (n = 4–5 mice per group; one representative of three independent experiments is shown). P < 0.001 for WT PMNs Inline graphic Alox5−/− vs. C5ar−/− PMNs Inline graphic Alox5−/− or Alox5−/− controls in clinical score and ankle thickening. Data are presented as mean ± SEM.